NCT06312774View on ClinicalTrials.gov

Feasibility of Proteomics in Chronic Lung Disease With Sarcopenia

Not yet recruitingOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

November 7, 2025

Study Completion Date

January 4, 2027

Conditions
SarcopeniaChronic Lung Disease
Interventions
OTHER

This is observational study

This is observational study

All Listed Sponsors
lead

University College, London

OTHER

NCT06312774 - Feasibility of Proteomics in Chronic Lung Disease With Sarcopenia | Biotech Hunter | Biotech Hunter